Royalty Pharma plc
Royalty Pharma plc (RPRX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
rprx · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Royalty Pharma plc (RPRX) has a market cap — also referred to as its net worth or valuation — of $23.9B, making it one of the top most valuable companies globally. Market Cap = $55.48 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Royalty Pharma plc (RPRX) has a market cap — also referred to as its net worth or valuation — of $23.9B as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Royalty Pharma plc reached its all-time high market cap of $27.0B on Dec 31, 2016. Comparing the Royalty Pharma plc market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Royalty Pharma plc net worth vs peers and ask how Royalty Pharma plc valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
RPRX market cap · 6 questionsRoyalty Pharma plc's net worth — measured as market capitalization — is $23.9B as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$55.48 (price) × shares outstanding.